State lawmakers across the country are preparing a new round of legislation to address the high prescription drug prices contributing to Americans’ increasing perception that health care is becoming unaffordable.
The push comes as federal policymakers face renewed pressure to reach bipartisan agreement on legislation imposing new regulations on pharmacy benefit managers, companies that have taken much of the blame for inflated drug prices.
Already a subscriber? Sign in